p53 regulates the expression of histone modifiers to restrict stemness and maintain differentiated luminal identity in breast cancer
Proceedings of the National Academy of Sciences · 2025
DOI: 10.1073/pnas.2522646122 ↗Kurz gefasst
Fachartikel in der Zeitschrift Proceedings of the National Academy of Sciences, 2025. Verfasst von Yael Aylon und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot 7610001, Israel. Hauptthemen laut MEDLINE: Breast Neoplasms, Tumor Suppressor Protein p53, Neoplastic Stem Cells, Histones. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 116 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Dr. Miriam and Sheldon G. Adelson Medical Research Foundation (AMRF), German-Israeli Cooperation in Cancer Research, Morris Kahn Institute for Human Immunology.
Abstract (Originalsprache)
Breast cancer is the leading cause of death in women under 50. The majority of breast cancers are estrogen receptor α-positive (ER+) and are commonly treated with hormonal therapies such as tamoxifen that inhibit ER activity. The TP53 tumor suppressor gene, encoding the p53 protein, is the most frequently mutated gene in breast cancer, and TP53 mutations are associated with diminished tamoxifen response and worse prognosis for breast cancer patients. Here, we report that in breast cancer cells p53 and ER cooperate to regulate the transcription of a set of genes encoding chromatin modifiers. The net result is a global increase in H3K4me3 and decrease in H3K9me3 chromatin marks. The resultant “open” chromatin is associated with increased transcription of luminal cell identity genes and enhanced tamoxifen sensitivity. Conversely, diminished p53 control of these chromatin modulators is associated with the evolution of tamoxifen resistance and cancer stem cell properties.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot 7610001, Israel.
- Department of Immunology and Regenerative Biology, Weizmann Institute of Science, Rehovot 7610001, Israel.
- Department of Systems Immunology, Weizmann Institute of Science, Rehovot 7610001, Israel.
- Division of Oncogenomics, Oncode Institute, The Netherlands Cancer Institute, Amsterdam 1066 CX, The Netherlands.
- Nancy and Stephen Grand Israel National Center for Personalized Medicine, Weizmann Institute of Science, Rehovot 7610001, Israel.
- Department of Veterinary Resources, Weizmann Institute of Science, Rehovot 7610001, Israel.
ORCID-Profile: Noa Furth, Nuno Padrão, Wilbert Zwart, Efrat Shema, Moshe Oren
Förderung
- Dr. Miriam and Sheldon G. Adelson Medical Research Foundation (AMRF)
- German-Israeli Cooperation in Cancer Research
- Morris Kahn Institute for Human Immunology
- Fabrikant-Morse Families Research Fund for Humanity
- Quinquin Foundation
- EC | ERC | HORIZON EUROPE European Research Council (ERC)
- Israel Science Foundation (ISF)
- Israel Cancer Research Fund (ICRF)
Zitieren
APA
Aylon, Y., Furth, N., Pirona, A. C., Lavie, A., Fedorova, O., Hassin, O., Padrão, N., Steinmetz, M., Sarusi-Potuguez, A., Fellus-Alyagor, L., Shimoni, I., Dassa, B., Zwart, W., Shema, E., & Oren, M. (2025). p53 regulates the expression of histone modifiers to restrict stemness and maintain differentiated luminal identity in breast cancer. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.2522646122
Vancouver
Aylon Y, Furth N, Pirona AC, Lavie A, Fedorova O, Hassin O, et al. p53 regulates the expression of histone modifiers to restrict stemness and maintain differentiated luminal identity in breast cancer. Proceedings of the National Academy of Sciences. 2025. doi:10.1073/pnas.2522646122
BibTeX
@article{Aylon2025,
author = {Aylon, Yael and Furth, Noa and Pirona, Anna C and Lavie, Adi and Fedorova, Olga and Hassin, Ori and Padrão, Nuno and Steinmetz, Maxime and Sarusi-Potuguez, Avital and Fellus-Alyagor, Liat and Shimoni, Irit and Dassa, Bareket and Zwart, Wilbert and Shema, Efrat and Oren, Moshe},
title = {p53 regulates the expression of histone modifiers to restrict stemness and maintain differentiated luminal identity in breast cancer},
journal = {Proceedings of the National Academy of Sciences},
year = {2025},
doi = {10.1073/pnas.2522646122}
}
EUVIMED